Market Research Logo

SeraCare Life Sciences, Inc. - Strategic SWOT Analysis Review

SeraCare Life Sciences, Inc. - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products include next-gen sequencing and digital PCR tools, controls and reference materials, validation and lot qualification materials; plasma and serum diluents/derivatives; cell culture reagents; antibodies and conjugates; and immunoassay reagents and kits. SeraCare’s major customers include IVD manufacturers; government and regulatory agencies; and pharmaceutical and biotechnology companies; veterinary companies; and academic and government research organizations. It has facilities in Milford, Massachusetts and Gaithersburg, Maryland. The company distributes its products through a network of distributors in several countries the world over. SeraCare is headquartered in Milford, Massachusetts, the US.

SeraCare Life Sciences, Inc. Key Recent Developments

Apr 16,2018: SeraCare Announces Expansion of Industry's Most Complete and Patient-Like ctDNA Reference Materials
Feb 13,2018: SeraCare Announces Industry's First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer
Jan 08,2018: SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman
Nov 08,2017: SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies
Aug 01,2017: SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
SeraCare Life Sciences, Inc. - Key Facts
SeraCare Life Sciences, Inc. - Key Employees
SeraCare Life Sciences, Inc. - Key Employee Biographies
SeraCare Life Sciences, Inc. - Major Products and Services
SeraCare Life Sciences, Inc. - History
SeraCare Life Sciences, Inc. - Company Statement
SeraCare Life Sciences, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
SeraCare Life Sciences, Inc. - Business Description
SeraCare Life Sciences, Inc. - Corporate Strategy
SeraCare Life Sciences, Inc. - SWOT Analysis
SWOT Analysis - Overview
SeraCare Life Sciences, Inc. - Strengths
SeraCare Life Sciences, Inc. - Weaknesses
SeraCare Life Sciences, Inc. - Opportunities
SeraCare Life Sciences, Inc. - Threats
SeraCare Life Sciences, Inc. - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Type, 2012 to YTD 2018
SeraCare Life Sciences, Inc., Recent Deals Summary
Section 4 – Company’s Recent Developments
Apr 16, 2018: SeraCare Announces Expansion of Industry's Most Complete and Patient-Like ctDNA Reference Materials
Feb 13, 2018: SeraCare Announces Industry's First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer
Jan 08, 2018: SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman
Nov 08, 2017: SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies
Aug 01, 2017: SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing
Jul 18, 2017: SeraCare Life Sciences Announces the Most Patient-Like cfDNA QC Technology
Mar 23, 2017: SeraCare Life Sciences announces launch of industry's first multiplexed Inherited Cancer reference material
Feb 21, 2017: SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards
Feb 08, 2017: SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
SeraCare Life Sciences, Inc., Key Facts
SeraCare Life Sciences, Inc., Key Employees
SeraCare Life Sciences, Inc., Key Employee Biographies
SeraCare Life Sciences, Inc., Major Products and Services
SeraCare Life Sciences, Inc., History
SeraCare Life Sciences, Inc., Other Locations
SeraCare Life Sciences, Inc., Subsidiaries
SeraCare Life Sciences, Inc., Key Competitors
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Type, 2012 to YTD 2018
SeraCare Life Sciences, Inc., Recent Deals Summary
List of Figures
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018
SeraCare Life Sciences, Inc., Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report